Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)
Clinical trial NCT07499362 · RECRUITING
Trial details
- NCT number
- NCT07499362
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2029-11-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.